11-44095822-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_207122.2(EXT2):​c.-61C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0504 in 166,824 control chromosomes in the GnomAD database, including 329 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.049 ( 284 hom., cov: 33)
Exomes 𝑓: 0.064 ( 45 hom. )

Consequence

EXT2
NM_207122.2 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.43

Publications

1 publications found
Variant links:
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
EXT2 Gene-Disease associations (from GenCC):
  • exostoses, multiple, type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • seizures-scoliosis-macrocephaly syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary multiple osteochondromas
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 11-44095822-C-G is Benign according to our data. Variant chr11-44095822-C-G is described in ClinVar as [Benign]. Clinvar id is 304568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0767 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EXT2NM_207122.2 linkc.-61C>G 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 14 ENST00000533608.7 NP_997005.1 Q93063-1
EXT2NM_207122.2 linkc.-61C>G 5_prime_UTR_variant Exon 1 of 14 ENST00000533608.7 NP_997005.1 Q93063-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EXT2ENST00000533608.7 linkc.-61C>G 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 14 1 NM_207122.2 ENSP00000431173.2 Q93063-1
EXT2ENST00000533608.7 linkc.-61C>G 5_prime_UTR_variant Exon 1 of 14 1 NM_207122.2 ENSP00000431173.2 Q93063-1

Frequencies

GnomAD3 genomes
AF:
0.0491
AC:
7471
AN:
152136
Hom.:
284
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0138
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0375
Gnomad ASJ
AF:
0.0228
Gnomad EAS
AF:
0.000776
Gnomad SAS
AF:
0.0186
Gnomad FIN
AF:
0.0663
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0784
Gnomad OTH
AF:
0.0440
GnomAD4 exome
AF:
0.0639
AC:
931
AN:
14580
Hom.:
45
Cov.:
0
AF XY:
0.0609
AC XY:
446
AN XY:
7320
show subpopulations
African (AFR)
AF:
0.0266
AC:
5
AN:
188
American (AMR)
AF:
0.0515
AC:
7
AN:
136
Ashkenazi Jewish (ASJ)
AF:
0.0213
AC:
8
AN:
376
East Asian (EAS)
AF:
0.00
AC:
0
AN:
366
South Asian (SAS)
AF:
0.0192
AC:
20
AN:
1040
European-Finnish (FIN)
AF:
0.0675
AC:
44
AN:
652
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
60
European-Non Finnish (NFE)
AF:
0.0733
AC:
788
AN:
10748
Other (OTH)
AF:
0.0582
AC:
59
AN:
1014
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0491
AC:
7472
AN:
152244
Hom.:
284
Cov.:
33
AF XY:
0.0474
AC XY:
3526
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0138
AC:
575
AN:
41574
American (AMR)
AF:
0.0375
AC:
573
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0228
AC:
79
AN:
3472
East Asian (EAS)
AF:
0.000778
AC:
4
AN:
5140
South Asian (SAS)
AF:
0.0186
AC:
90
AN:
4832
European-Finnish (FIN)
AF:
0.0663
AC:
704
AN:
10616
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.0784
AC:
5333
AN:
67992
Other (OTH)
AF:
0.0435
AC:
92
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
399
798
1197
1596
1995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0623
Hom.:
54
Bravo
AF:
0.0456
Asia WGS
AF:
0.00812
AC:
29
AN:
3464

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Exostoses, multiple, type 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
19
DANN
Benign
0.89
PhyloP100
1.4
PromoterAI
-0.034
Neutral
Mutation Taster
=297/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12800404; hg19: chr11-44117372; API